Xin Lang Cai Jing·2025-09-15 03:16Company Overview - Fosun Pharma's stock price increased by 2.03% on September 15, reaching 32.16 CNY per share, with a trading volume of 8.01 billion CNY and a turnover rate of 1.19%, resulting in a total market capitalization of 858.81 billion CNY [1] - The company was established on May 31, 1995, and listed on August 7, 1998, with its main business focusing on drug manufacturing and research, covering medical devices, medical services, and pharmaceutical distribution and retail [1] Financial Performance - For the first half of 2025, Fosun Pharma reported a revenue of 19.514 billion CNY, a year-on-year decrease of 4.63%, while the net profit attributable to shareholders increased by 38.96% to 1.702 billion CNY [2] - The company has distributed a total of 12.593 billion CNY in dividends since its A-share listing, with 2.691 billion CNY distributed over the past three years [2] Stockholder Information - As of June 30, 2025, the number of shareholders decreased by 4.37% to 230,000, with an average of 0 circulating shares per shareholder [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 75.8807 million shares, an increase of 11.1938 million shares from the previous period [3]